TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Clinical trial NCT06106841 · TERMINATED
Trial details
- NCT number
- NCT06106841
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-05
- Primary completion
- 2024-10-16
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.